Publications by authors named "Eric Fedyk"

Claim this Profile
A
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose and Multiple-Rising-Dose Study of the BTK Inhibitor TAK-020 in Healthy Subjects.
Ehsanollah Esfandiari, Mary Chen, Glennda Smithson, Derek Blair, Helene Faessel, Eric R Fedyk

Clin Transl Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti-CD38 cytolytic antibody TAK-079 in healthy subjects.
Eric R Fedyk, Lin Zhao, Annelize Koch, Glennda Smithson, Jose Estevam

Br J Clin Pharmacol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Reduction in B, T, and Natural Killer Cells Expressing CD38 by TAK-079 Inhibits the Induction and Progression of Collagen-Induced Arthritis in Cynomolgus Monkeys.
Wouter Korver, Mary Carsillo, Josh Yuan, Neeraja Idamakanti, Matthew Wagoner, Eric R Fedyk

J Pharmacol Exp Ther· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.
Keiko Igaki, Yusaku Komoike, Yoshiki Nakamura, Takeshi Watanabe, Masashi Yamasaki, Eric Fedyk

Int Immunopharmacol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of the cytolytic anti-CD38 human monoclonal antibody TAK-079 in monkey - model assisted preparation for the first in human trial.
Stefan Roepcke, Nele Plock, Josh Yuan, Eric R Fedyk, Gezim Lahu

Pharmacol Res Perspect· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab.
Maria Rosario, Nathanael L Dirks, Catherine Milch, Asit Parikh, Michael Bargfrede, Eric Fedyk

Clin Pharmacokinet· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab.
Tim Wyant, Eric Fedyk, Brihad Abhyankar

J Crohns Colitis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytes.
Timothy Wyant, Lili Yang, Eric Fedyk

MAbs· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonizing the α4β1 integrin, but not α4β7, inhibits leukocytic infiltration of the central nervous system in rhesus monkey experimental autoimmune encephalomyelitis.
Krista G Haanstra, Sam O Hofman, Dave M Lopes Estêvão, Erwin L A Blezer, Jan Bauer, Eric R Fedyk

J Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exclusive antagonism of the α4 β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates.
Eric R Fedyk, Tim Wyant, Li-Li Yang, Vilmos Csizmadia, Kristine Burke

Inflamm Bowel Dis· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases.
Dulce Soler, Tobias Chapman, Li-Li Yang, Tim Wyant, Robert Egan, Eric R Fedyk

J Pharmacol Exp Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of an experimental proteasome inhibitor on the cytoskeleton, cytosolic protein turnover, and induction in the neuronal cells in vitro.
Vilmos Csizmadia, Arek Raczynski, Eva Csizmadia, Eric R Fedyk, James Rottman

Neurotoxicology· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes.
Dulce Soler, Tobias R Chapman, Louis R Poisson, Lin Wang, Javier Cote-Sierra, Eric Fedyk

J Immunol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of serpin-protease expression by comparative analysis of real-time PCR profiling data.
Sunita Badola, Heidi Spurling, Keith Robison, Eric R Fedyk, Gary A Silverman

Genomics· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2).
Fang Liu, Jose Angel Gonzalo, Stephen Manning, Laura E O'Connell, Eric R Fedyk

Prostaglandins Other Lipid Mediat· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of regulator of G protein signaling 16 in inflammation-induced T lymphocyte migration and activation.
Eric Lippert, David L Yowe, Jose-Angel Gonzalo, J Paul Justice, Jeremy M Webster, Eric R Fedyk

J Immunol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis